Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease
Open accessAbstract
Background —Elevated C-reactive protein (CRP) serum levels, an exquisitely sensitive objective marker of inflammation, relate to long-term prognosis in patients with coronary artery disease and in apparently healthy men. Because abnormalities of endothelial regulation of vascular function may contribute to the occurrence of coronary events, we tested the hypothesis that elevated CRP levels are associated with an abnormal systemic endothelial vascular reactivity. Methods and Results —Endothelium-dependent (10 to 50 μg/min acetylcholine) and endothelium-independent (2 to 8 μg/min sodium nitroprusside) forearm blood flow responses were measured with venous occlusion plethysmography in 60 male patients with angiographically documented coronary artery disease. Forearm blood flow responses to acetylcholine were inversely correlated with CRP serum levels ( r =−0.46, P =0.001). With multivariate analysis that included the classic risk factors for coronary artery disease, elevated CRP serum level remained a statistically significant independent predictor of a blunted endothelial vasodilator capacity. Most important, normalization of elevated CRP levels over time was associated with a normalization of endothelium-mediated forearm blood flow responses after 3 months. Conclusions —Thus, elevated CRP serum levels indicative of a systemic inflammatory response are associated with a blunted systemic endothelial vasodilator function. The identification of elevated CRP levels as a transient independent risk factor for endothelial dysfunction might provide an important clue to link a systemic marker of inflammation to atherosclerotic disease progression.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inflammation is associated with anabolic resistance in muscle, caused partly by inhibition of perfusion adjustment to anabolic stimuli and partly by inhibition of IGF1 production and signalling.
“inflammation is associated with anabolic resistance in muscle, which is caused partly by inhibition of the perfusion adjustment to anabolic stimuli and partly by inhibition of IGF1 production and signalling”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [240]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works
Analysis of serial measurements in medical research.
Matthews, J. N. S., Altman, D. G., Campbell, M. J., & Royston, P. J. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,137 · see citing works
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354 · see citing works
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952 · see citing works
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,870 · see citing works
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511 · see citing works
The measurement of volume changes in human limbs
Whitney, R. J. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004926 · Cited by 1,496 · see citing works
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117 · see citing works
Zeiher, A. M., Drexler, H., Wollschläger, H., & Just, H. (1991) · Circulation · doi:10.1161/01.cir.83.2.391 · Cited by 994 · see citing works
Self-citationC-Reactive Protein as a Cardiovascular Risk Factor
Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833 · see citing works
Hypertension and the Pathogenesis of Atherosclerosis
Alexander, R. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.155 · Cited by 785 · see citing works
Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., & D, E. B. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00136-3 · Cited by 780 · see citing works
Elevated Levels of Interleukin-6 in Unstable Angina
Biasucci, L. M., Vitelli, A., Liuzzo, G., Altamura, S., Caligiuri, G., Monaco, C. G., Rebuzzi, A. G., Ciliberto, G., & Maseri, A. (1996) · Circulation · doi:10.1161/01.cir.94.5.874 · Cited by 738 · see citing works
Roles of Infectious Agents in Atherosclerosis and Restenosis
Libby, P., Egan, D., & Skarlatos, S. I. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 559 · see citing works
Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia
Chowienczyk, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92621-l · Cited by 466 · see citing works
Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and Mediators
Benjamin, N., Calver, A., Collier, J., Robinson, B. F., Vallance, P. J., & Webb, D. J. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.918 · Cited by 399 · see citing works
Novel Inflammatory Markers of Coronary Risk
Libby, P., & Ridker, P. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1148 · Cited by 375 · see citing works
An Electrically Calibrated Plethysmograph for Direct Measurement of Limb Blood Flow
Hokanson, D. E., Sumner, D. S., & Strandness, D. E. (1975) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.1975.324535 · Cited by 313 · see citing works
Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?
Vallance, P. J., Collier, J., & Bhagat, K. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09424-x · Cited by 308 · see citing works
O’Driscoll, G., GREEN, D. J., Rankin, J., Stanton, K., & Taylor, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119580 · Cited by 217 · see citing works
Dawes, M., Chowienczyk, P., & Ritter, J. M. (1997) · Circulation · doi:10.1161/01.cir.95.9.2293 · Cited by 212 · see citing works
Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation
Wang, P., Ba, Z. F., & Chaudry, I. H. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2535 · Cited by 153 · see citing works
Bhagat, K., Moss, R. F., Collier, J., & Vallance, P. J. (1996) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00123-x · Cited by 152 · see citing works
Endothelial vasodilator dysfunction: Pathogenetic link to myocardial ischaemia or epiphenomenon?
Zeiher, A. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98004-6 · Cited by 107 · see citing works
Self-citation
Flagged first, then by citations
1 of the 25 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works
“Elevated CRP levels have been similarly associated with blunted endothelial vasoreactivity and, perhaps more importantly, CRP normalization is associated with subsequent improvement of regional blood flow.(47) In addition, crosssectional analyses show that CRP is Figure 2.”
BackgroundInflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · see citing works
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513 · see citing works
Air Pollution and Cardiovascular Disease
Brook, R. D., Franklin, B. A., Cascio, W. E., Hong, Y., Howard, G., D, M. L. M., Luepker, R. V., Mittleman, M. A., Samet, J. M., Smith, S. C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128587.30041.c8 · Cited by 2,417 · see citing works
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961 · see citing works
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749 · see citing works
“mation, including increased levels of C-reactive protein (7), are also associated with endothelial dysfunction in human subjects (8,42,43).”
BackgroundRidker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402 · see citing works
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits‐Filho, R., RIELLA, M. C., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 933 · see citing works
Venugopal, S. K., Devaraj, S., Yuhanna, I. S., Shaul, P. W., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 849 · see citing works
Endothelial Function: A Critical Determinant in Atherosclerosis?
Landmesser, U., Hornig, B., & Drexler, H. (2004) · Circulation · doi:10.1161/01.cir.0000129501.88485.1f · Cited by 851 · see citing works
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
Hadi, H. A. R., Carr, C. S., & Suwaidi, J. M. S. A. (2005) · PubMed Central · Cited by 807 · see citing works
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799 · see citing works
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754 · see citing works
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 619 · see citing works
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Jialal, I., Devaraj, S., & Venugopal, S. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000130484.20501.df · Cited by 569 · see citing works
Endothelial Function Testing as a Biomarker of Vascular Disease
Verma, S., Buchanan, M. R., & Anderson, T. J. (2003) · Circulation · doi:10.1161/01.cir.0000089191.72957.ed · Cited by 565 · see citing works
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.
Rifai, N., & Ridker, P. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.403 · Cited by 592 · see citing works
“Finally, physical exercise has been shown to have a beneficial effect in terms of reducing the concentration of several inflammatory markers (47, 48 ). Taken together, the available evidence thus supports the hypothesis that hs-CRP concentrations correlate with endothelial dysfunction ( 49 ).”
ResultEndothelial dysfunction: a comprehensive appraisal.
Esper, R. J., Nordaby, R. A., Vilariño, J. O., Paragano, A. J., Cacharrón, J. L., & Machado, R. A. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-4 · Cited by 493 · see citing works
JCS Joint Working Group (2014) · Circulation Journal · doi:10.1253/circj.cj-66-0098 · Cited by 460 · see citing works
Diabetes Mellitus, Aortic Stiffness, and Cardiovascular Mortality in End-Stage Renal Disease
Shoji, T., Emoto, M., Shinohara, K., Kakiya, R., TSUJIMOTO, Y., Kishimoto, H., Ishimura, E., Tabata, T., & Nishizawà, Y. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102117 · Cited by 450 · see citing works
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Salvetti, A., Ferrannini, E., & Monzani, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030039 · Cited by 431 · see citing works
“In this regard, all the patients had thyroiditis; and therefore, a possible concomitant effect of inflammation and autoimmunity should be not overlooked, because inflammatory states are associated with endothelial dysfunction (35).”
BackgroundC-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals
Yasmin, Y., McEniery, C. M., Wallace, S. M. L., Mackenzie, I. S., Cockcroft, J. R., & Wilkinson, I. B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.zhq0504.0173 · Cited by 400 · see citing works
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 366 · see citing works
Amar, S., Gokce, N., Morgan, S., Loukideli, M., Van Dyke, T. E., & Vita, J. A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000078603.90302.4a · Cited by 361 · see citing works
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L. E., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 354 · see citing works
Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension
Mahmud, A., & Feely, J. (2005) · Hypertension · doi:10.1161/01.hyp.0000185463.27209.b0 · Cited by 345 · see citing works
Endothelial dysfunction over the course of coronary artery disease
Gutiérrez, E., Flammer, A. J., Lerman, L. O., Elı́zaga, J., Lerman, A., & Fernández‐Avilés, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht351 · Cited by 334 · see citing works
“In patients with unstable angina, endothelium-dependent vasoreactivity parallels inflammatory activity as expressed by C-reactive protein levels.(66) Figure 3 Illustration of the post-stent epicardial reactivity to acetylcholine in the various studies referenced in the text(56) .”
BackgroundElevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children
Järvisalo, M. J., Harmoinen, A. P. T., Hakanen, M., Paakkunainen, U., Viikari, J. S. A., Hartiala, J., Lehtimäki, T. J., Simell, O., & Raitakari, O. T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000024222.06463.21 · Cited by 315 · see citing works
Human CRP Gene Polymorphism Influences CRP Levels
Brull, D. J., Serrano, N. C., Zito, F., Jones, L., Montgomery, H., Rumley, A., Sharma, P. K., Lowe, G. D. O., WORLD, M. J., Humphries, S. E., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000084640.21712.9c · Cited by 305 · see citing works
Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302 · see citing works
Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 297 · see citing works
Human C-reactive protein and the metabolic syndrome
Devaraj, S., Singh, U. S., & Jialal, I. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ac03e · Cited by 291 · see citing works
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 289 · see citing works
C-Reactive Protein and Glycemic Control in Adults With Diabetes
King, D. E., Mainous, A. G., Buchanan, T. A., & Pearson, W. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1535 · Cited by 281 · see citing works
“Other studies have related hyperglycemia to inflammation by demonstrating simultaneous inflammation, endothelial dysfunction, and insulin resistance at the physiologic level (23,24).”
BackgroundRay, K. K., & Cannon, C. P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.086 · Cited by 273 · see citing works
Statins and sepsis: multiple modifications at multiple levels
Terblanche, M., Almog, Y., Rosenson, R. S., Smith, T. S., & Hackam, D. G. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70111-1 · Cited by 269 · see citing works
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262 · see citing works
Roman, M. J., Naqvi, T. Z., Gardin, J. M., Gerhard‐Herman, M. D., Jaff, M. R., & Mohler, E. R. (2006) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2006.04.020 · Cited by 260 · see citing works
Endothelial function, inflammation, and prognosis in cardiovascular disease
Gonzalez, M. A., & Selwyn, A. P. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.016 · Cited by 258 · see citing works
McDermott, D. H., Halcox, J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M. (2001) · Circulation Research · doi:10.1161/hh1701.095642 · Cited by 256 · see citing works
Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes
Fichtlscherer, S., Breuer, S., & Zeiher, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000143378.58099.8c · Cited by 251 · see citing works
“Antidiabetics/insulin 8 (5)/7 (4) 1 (3)/4 (13) NS”
Self-citationC-reactive protein and cardiovascular disease: new insights from an old molecule
Hirschfield, G. M., & Pepys, M. B. (2003) · QJM · doi:10.1093/qjmed/hcg134 · Cited by 249 · see citing works
JCS Joint Working Group (2010) · Circulation Journal · doi:10.1253/circj.cj-10-74-0802 · Cited by 251 · see citing works
Kuvin, J. T., Patel, A. R., Sliney, K. A., Pandian, N. G., Rand, W. M., Udelson, J. E., & Karas, R. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01657-6 · Cited by 249 · see citing works
Brook, R. D., Bard, R. L., Rubenfire, M., Ridker, P. M., & Rajagopalan, S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02088-4 · Cited by 244 · see citing works
Donato, A. J., Black, A. D., Jablonski, K. L., Gano, L. B., & Seals, D. R. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00438.x · Cited by 237 · see citing works
The Evolving Role of C-Reactive Protein in Atherothrombosis
Devaraj, S., Singh, U. S., & Jialal, I. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108886 · Cited by 233 · see citing works
Correlation between cardiovascular disease and diabetes mellitus: current concepts
Nesto, R. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.016 · Cited by 232 · see citing works
Rachoń, D., Suchecka-Rachoń, K., Hak, Ł., & Myśliwska, J. M. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000227400.60816.52 · Cited by 229 · see citing works
“678 Serum E2 (pmol/L) 47 (33-102) 69 (14-112) 71 (26-96) 0.”
Folsom, A. R., Aleksic, N., Catellier, D., Juneja, H. S., & Wu, K. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124054 · Cited by 225 · see citing works
The Role of Inflammation in the Pathogenesis of Glaucoma
Vohra, R., Tsai, J. C., & Kolko, M. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.08.010 · Cited by 214 · see citing works
Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01409-0 · Cited by 198 · see citing works
“Proposed mechanisms through which low-grade inflammation might influence atherogenesis include accelerated foam cell formation by monocyte recruitment and native low-density lipoprotein cholesterol (LDL-c) uptake in the arterial wall [11, 12] Elevated CRP levels are also associated with blunted systemic endothelial va…”
BackgroundWeyer, C., Yudkin, J. S., Stehouwer, C. D. A., Schalkwijk, C. G., Pratley, R. E., & Tataranni, P. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00626-8 · Cited by 211 · see citing works
Endothelial Dysfunction in Obstructive Sleep Apnea
Budhiraja, R., Parthasarathy, S., & Quan, S. F. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26864 · Cited by 208 · see citing works
Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study
Vita, J. A., Keaney, J. F., Larson, M. G., Keyes, M. J., Massaro, J. M., Lipinska, I., Lehman, B. T., Fan, S., Osypiuk, E. W., Wilson, P. W. F., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148821.97162.5e · Cited by 204 · see citing works
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions
Chan, A. W., Bhatt, D. L., Chew, D. P., Reginelli, J. P., Schneider, J. P., Topol, E. J., & Ellis, S. G. (2003) · Circulation · doi:10.1161/01.cir.0000060541.18923.e9 · Cited by 206 · see citing works
Vázquez, L. A., Pazos, F., de Berrazueta, J. R., Fernández-Escalante, C., García‐Unzueta, M. T., Freijanes, J., & Amado, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032059 · Cited by 205 · see citing works
“Finally, because the possible correlation between venous and arterial dysfunction remains to be demonstrated in morbid obesity, discrepancies with previous reports in the associations between inflammatory markers and vasodilatory response (49, 50) may be related to different study protocols, i.”
ResultVidal, F., Figueredo, C. M., Cordovil, I., & Fischer, R. G. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080471 · Cited by 200 · see citing works
JCSJointWorkingGroup (2014) · Circulation · Cited by 199 · see citing works
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Ferrannini, E., Salvetti, A., & Monzani, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1075 · Cited by 196 · see citing works
Endothelial function and inflammation in coronary artery disease
Tousoulis, D., Charakida, M., & Stefanadis, C. (2005) · Postgraduate Medical Journal · doi:10.1136/hrt.2005.066936 · Cited by 195 · see citing works
Inflammation and Atherosclerosis
Jialal, I., & Devaraj, S. (2001) · Pathology Patterns Reviews · doi:10.1309/j63v-5lth-wyfc-vdr5 · Cited by 195 · see citing works
Scirica, B. M., & Morrow, D. A. (2006) · Circulation · doi:10.1161/circulationaha.105.611350 · Cited by 187 · see citing works
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186 · see citing works
C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells
Venugopal, S. K., Devaraj, S., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000094736.10595.a1 · Cited by 184 · see citing works
Yiu, Y.-F., Yiu, K., Siu, C., Chan, Y., Li, S.-W., Wong, L.-Y., Lee, S. W. L., Tam, S., Wong, E. W. K., Lau, C., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.013 · Cited by 183 · see citing works
Inflammation and Endothelial Function
Clapp, B. R., Hirschfield, G. M., Storry, C., Gallimore, J. R., Stidwill, R. P., Singer, M., Deanfield, J. E., MacAllister, R. J., Pepys, M. B., Vallance, P. J., et al. (2005) · Circulation · doi:10.1161/01.cir.0000159336.31613.31 · Cited by 181 · see citing works
Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo
Hein, T. W., Singh, U. S., Vasquez-Vivar, J. M., Devaraj, S., Kuo, L., & Jialal, I. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.002 · Cited by 178 · see citing works
Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation
Silva, I. V. G., de Figueiredo, R. C., & Rios, D. R. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143458 · Cited by 180 · see citing works
“First- or second-generation β-blockers do not appear to improve arterial stiffness, inflammatory cytokine expression, NO-dependent vasodilation, or oxidative stress in patients with hypertension [21,40,73].”
BackgroundDietary saturated and unsaturated fats as determinants of blood pressure and vascular function
Hall, W. L. (2009) · Nutrition Research Reviews · doi:10.1017/s095442240925846x · Cited by 168 · see citing works
“Another method involves venous occlusion plethysmography to measure forearm blood flow in peripheral resistance vessels following infusion of acetylcholine((10)).”
Brevetti, G., Silvestro, A., Giacomo, S. D., Bucur, R., Donato, A. D., Schiano, V., & Scopacasa, F. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00124-1 · Cited by 165 · see citing works
“Age (y) 62 8 65 10 Sex (M/F) 27/3 81/7 Hypertension 6 (20) 48 (55)* Systolic BP (mm Hg) 136 11 145 18* Diastolic BP (mm Hg) 80 7 82 10 Smoking status Current 5 (17) 46 (52)* Former 10 (33) 35 (40) Hyperlipidemia 4 (13) 48 (55)* Cholesterolemia (mg/dL) 221 48 217 46 HDL-cholesterol (mg/dL) 43 8 41 9 Triglyceride level…”
Cosı́n-Sales, J., Pizzi, C., Brown, S., & Kaski, J. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00243-2 · Cited by 165 · see citing works
C-Reactive Protein Enhances LOX-1 Expression in Human Aortic Endothelial Cells
Li, L., Roumeliotis, N., Sawamura, T., & Renier, G. (2004) · Circulation Research · doi:10.1161/01.res.0000147309.54227.42 · Cited by 159 · see citing works
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
de Ferranti, S. D., & Rifai, N. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00797-5 · Cited by 159 · see citing works
Adaptive changes in autogenous vein grafts for arterial reconstruction: Clinical implications
Owens, C. D. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.07.102 · Cited by 157 · see citing works
“[95][96][97] Further, in a cohort of patients undergoing vascular surgery, impaired FMD has been shown to be independently associated with adverse 30-day cardiovascular outcomes.”
BackgroundEndothelial Dysfunction, Vascular Disease and Stroke: The ARTICO Study
Roquer, J., Segura, T., Serena, J. L., & Castillo, J. (2009) · Cerebrovascular Diseases · doi:10.1159/000200439 · Cited by 156 · see citing works
Venugopal, S. K., Devaraj, S., & Jialal, I. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62345-0 · Cited by 156 · see citing works
Accelerated atherogenesis in autoimmune rheumatic diseases
Bacon, P. A., Stevens, R. J., Carruthers, D. M., Young, S. P., & Kitas, G. D. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00100-3 · Cited by 155 · see citing works
The ENCORE Investigators (2003) · Circulation · doi:10.1161/01.cir.0000046488.52939.bf · Cited by 154 · see citing works
Health Effects of Particulate Matter
Myong, J. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.91.2.106 · Cited by 152 · see citing works
“연쇄적인 증가(fibrinogen [37], IL-6농도[38], CRP [39,40])를”
C-reactive protein and arterial stiffness in older adults: the Rotterdam Study
Mattace-Raso, F. U. S., van der Cammen, T. J. M., van der Meer, I. M., Schalekamp, M. A. D. H., Asmar, R. G., Albert Hofman, D., & Witteman, J. C. M. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.014 · Cited by 149 · see citing works
Fichtlscherer, S., Rössig, L., Breuer, S., Vasa‐Nicotera, M., Dimmeler, S., & Zeiher, A. M. (2001) · Circulation · doi:10.1161/hc5001.101749 · Cited by 147 · see citing works
Self-citationA prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia
Qiu, C. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.011 · Cited by 145 · see citing works
Clinical Utility of Endothelial Function Testing
Kuvin, J. T., & Karas, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000075928.54461.33 · Cited by 143 · see citing works
Heitzer, T. A., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., Tschentscher, P., Meinertz, T., Böger, R. H., & Baldus, S. E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225288.74170.dc · Cited by 141 · see citing works
Yavuz, D. G., Deyneli, O., Akpınar, İ., Yildiz, E., Gözü, H. I., Sezgin, O., Haklar, G., & Akalın, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490187 · Cited by 141 · see citing works
“Low-grade chronic inflammation, characterized by elevated concentrations of hsCRP, is associated with increased risk of atherosclerotic cardiovascular disease (21 ‐ 23) and endothelial dysfunction ( 23 ).”
BackgroundFichtlscherer, S., Schmidt‐Lucke, C., Bojunga, S., Rössig, L., Heeschen, C., Dimmeler, S., & Zeiher, A. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi881 · Cited by 141 · see citing works
“At the time of the FBF study, blood samples were collected, and serum and plasma were aliquoted and stored at 2808C until analysed for the measurement of high-sensitive C-reactive protein (hs-C-reactive protein) using an ultrasensitive assay (N Latex C-reactive protein mono; Behring) as described.(6) Serum lipid level…”
MethodSelf-citationC-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling
Singh, U. S., Devaraj, S., Vasquez-Vivar, J. M., & Jialal, I. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.015 · Cited by 139 · see citing works
Guven, M. A., Coşkun, A., Ertaş, İ. E., Aral, M., Zencirci, B., & Öksüz, H. (2009) · Hypertension in Pregnancy · doi:10.1080/10641950802601179 · Cited by 137 · see citing works
“84** Gravidity** 3 [1–10] 2.”
Effects of Systemic Inflammation on Endothelium-Dependent Vasodilation
Huang, A. L., & Vita, J. A. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.10.002 · Cited by 137 · see citing works
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Reference Study population Inflammatory marker Assessment of endothelial function Results coronary microcirculation Vita et al. (2004) 2701 Community-based subjects CRP, IL-6, MCP-1, and sICAM-1 Brachial artery FMD and reactive hyperem…”
BackgroundEndothelial dysfunction and inflammation—is there a link?
Stenvinkel, P. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.10.1968 · Cited by 136 · see citing works
The Endothelium and Inflammation
Trepels, T., Zeiher, A. M., & Fichtlscherer, S. (2006) · Endothelium · doi:10.1080/10623320601061862 · Cited by 136 · see citing works
Self-citationNeed to Test the Arterial Inflammation Hypothesis
Bhatt, D. L., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000021112.29409.a2 · Cited by 136 · see citing works
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers
Hetzel, J., Balletshofer, B. M., Rittig, K., Walcher, D., Kratzer, W., Hombach, V., Häring, H., Köenig, W., & Marx, N. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000176192.16951.9a · Cited by 136 · see citing works
Forearm reactive hyperemia and mortality in end-stage renal disease
London, G. M., Pannier, B., Agharazii, M., Guérin, A. P., Verbeke, F., & Marchais, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00434.x · Cited by 134 · see citing works
Schindler, T. H., Hornig, B., Buser, P. T., Olschewski, M., Magosaki, N., Pfisterer, M. E., Nitzsche, E. U., Solzbach, U., & Just, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000057571.03012.f4 · Cited by 132 · see citing works
Inflammation and atherosclerosis in rheumatoid arthritis
Stevens, R. J., Douglas, K., Saratzis, A. N., & Kitas, G. D. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405009154 · Cited by 131 · see citing works
Isasi, C. R., Deckelbaum, R. J., Tracy, R. P., Starc, T. J., Berglund, L., & Shea, S. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.332 · Cited by 129 · see citing works
American Society of Echocardiography Report
Roman, M. J., Naqvi, T. Z., Gardin, J. M., Gerhard‐Herman, M. D., Jaff, M. R., & Mohler, E. R. (2006) · Vascular Medicine · doi:10.1177/1358863x06070511 · Cited by 129 · see citing works
Fichtlscherer, S., Dimmeler, S., Breuer, S., Busse, R., Zeiher, A. M., & Fleming, I. (2003) · Circulation · doi:10.1161/01.cir.0000105763.51286.7f · Cited by 128 · see citing works
Self-citation
- Authors
- Fichtlscherer, S., Rosenberger, G., Walter, D. H., Breuer, S., Dimmeler, S., & Zeiher, A. M.
- Affiliations
- Goethe University Frankfurt (DE)
- Venue
- Circulation
- Published
- 2000-08-29
- Volume
- 102
- Issue
- 9
- Pages
- 1000-1006
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2076633296
- Cited by
- 665
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 11 · 2018: 17 · 2017: 16 · 2016: 18 · 2015: 18 · 2014: 26 · 2013: 27 · 2012: 21
- FWCI
- 23.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- C-reactive protein, coronary artery disease, endothelial dysfunction, endothelium-dependent vasodilation, acetylcholine response, forearm blood flow, systemic inflammation, cardiovascular risk factors, atherosclerosis, sodium nitroprusside
- MeSH terms
- Acetylcholine, Adrenergic beta-Antagonists, Aspirin, Brachial Artery, C-Reactive Protein, Coronary Disease, Endothelium, Vascular, Follow-Up Studies, Forearm, Humans, Inflammation, Infusions, Intra-Arterial, Male, Middle Aged, Nitroprusside, Regional Blood Flow, Risk Factors, Vasodilation, Vasodilator Agents, Biomarkers, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
